VIKING GLOBAL INVESTORS LP - Q4 2020 holdings

$36.4 Billion is the total value of VIKING GLOBAL INVESTORS LP's 96 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 131.6% .

 Value Shares↓ Weighting
MSFT BuyMICROSOFT CORP$2,633,028,000
+51.6%
11,838,092
+43.4%
7.24%
+15.4%
FIS BuyFIDELITY NATL INFORMATION SV$1,674,237,000
+28.0%
11,835,412
+33.2%
4.60%
-2.6%
TMUS BuyT-MOBILE US INC$1,173,934,000
+27.2%
8,705,481
+7.9%
3.23%
-3.2%
GOOGL BuyALPHABET INCcap stk cl a$1,086,270,000
+286.1%
619,791
+222.9%
2.99%
+194.0%
BSX BuyBOSTON SCIENTIFIC CORP$1,078,173,000
+49.9%
29,990,892
+59.3%
2.96%
+14.1%
UNH NewUNITEDHEALTH GROUP INC$979,682,0002,793,665
+100.0%
2.69%
V BuyVISA INC$893,630,000
+1289.6%
4,085,538
+1170.4%
2.46%
+959.1%
ABCL NewABCELLERA BIOLOGICS INC$775,978,00019,283,744
+100.0%
2.13%
DIS NewDISNEY WALT CO$773,911,0004,271,505
+100.0%
2.13%
PANW NewPALO ALTO NETWORKS INC$670,667,0001,887,130
+100.0%
1.84%
FLT BuyFLEETCOR TECHNOLOGIES INC$619,255,000
+453.6%
2,269,747
+383.1%
1.70%
+321.5%
ZBH BuyZIMMER BIOMET HOLDINGS INC$595,877,000
+159.0%
3,867,074
+128.8%
1.64%
+97.1%
FTV BuyFORTIVE CORP$564,006,000
+8.6%
7,963,937
+16.8%
1.55%
-17.4%
MCO BuyMOODYS CORP$477,567,000
+26.8%
1,645,420
+26.6%
1.31%
-3.5%
NOW NewSERVICENOW INC$422,789,000768,107
+100.0%
1.16%
CI BuyCIGNA CORP NEW$406,756,000
+66.0%
1,953,869
+35.1%
1.12%
+26.3%
HIG NewHARTFORD FINL SVCS GROUP INC$395,322,0008,071,081
+100.0%
1.09%
SE BuySEA LTDsponsord ads$379,191,000
+200.4%
1,905,002
+132.4%
1.04%
+128.7%
AVTR BuyAVANTOR INC$376,048,000
+103.5%
13,358,729
+62.6%
1.03%
+54.8%
OTIS BuyOTIS WORLDWIDE CORP$364,612,000
+94.9%
5,397,663
+80.1%
1.00%
+48.4%
VRSN BuyVERISIGN INC$317,394,000
+137.2%
1,466,699
+124.6%
0.87%
+80.7%
GE NewGENERAL ELECTRIC CO$315,360,00029,199,997
+100.0%
0.87%
HCA NewHCA HEALTHCARE INC$287,508,0001,748,194
+100.0%
0.79%
FB NewFACEBOOK INCcl a$281,881,0001,031,928
+100.0%
0.78%
HZNP BuyHORIZON THERAPEUTICS PUB L$267,939,000
+193.9%
3,662,876
+212.1%
0.74%
+124.0%
APD NewAIR PRODS & CHEMS INC$173,932,000636,600
+100.0%
0.48%
FDMT New4D MOLECULAR THERAPEUTICS IN$163,227,0003,937,914
+100.0%
0.45%
MET NewMETLIFE INC$156,836,0003,340,480
+100.0%
0.43%
MMC NewMARSH & MCLENNAN COS INC$154,507,0001,320,572
+100.0%
0.42%
MTCH NewMATCH GROUP INC NEW$138,291,000914,686
+100.0%
0.38%
BDX NewBECTON DICKINSON & CO$128,009,000511,584
+100.0%
0.35%
CTLT BuyCATALENT INC$125,263,000
+23.3%
1,203,641
+1.5%
0.34%
-6.3%
PODD BuyINSULET CORP$123,605,000
+143.8%
483,529
+125.6%
0.34%
+85.8%
RPRX BuyROYALTY PHARMA PLC$114,464,000
+39.7%
2,287,000
+17.4%
0.32%
+6.4%
BILI NewBILIBILI INCspons ads rep z$112,386,0001,311,083
+100.0%
0.31%
EQH NewEQUITABLE HLDGS INC$99,138,0003,874,110
+100.0%
0.27%
PGR NewPROGRESSIVE CORP$88,510,000895,126
+100.0%
0.24%
MCFE NewMCAFEE CORP$87,646,0005,251,436
+100.0%
0.24%
DASH NewDOORDASH INCcl a$87,159,000610,573
+100.0%
0.24%
KMX NewCARMAX INC$75,024,000794,240
+100.0%
0.21%
KNTE NewKINNATE BIOPHARMA INC$74,469,0001,872,023
+100.0%
0.20%
ARNA NewARENA PHARMACEUTICALS INC$32,826,000427,256
+100.0%
0.09%
ACHC NewACADIA HEALTHCARE COMPANY IN$17,179,000341,799
+100.0%
0.05%
SEER NewSEER INC$15,171,000270,232
+100.0%
0.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC38Q1 20247.0%
AMAZON COM INC37Q2 202410.6%
META PLATFORMS INC37Q2 202410.4%
MICROSOFT CORP32Q2 20249.1%
THERMO FISHER SCIENTIFIC INC31Q1 20245.4%
NETFLIX INC27Q2 20246.0%
MASTERCARD INCORPORATED27Q1 20243.9%
UNITEDHEALTH GROUP INC25Q2 20245.3%
BIOMARIN PHARMACEUTICAL INC25Q2 20242.7%
ELEVANCE HEALTH INC24Q2 202310.2%

View VIKING GLOBAL INVESTORS LP's complete holdings history.

Latest significant ownerships (13-D/G)
VIKING GLOBAL INVESTORS LP Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
APi Group CorpJune 18, 202427,032,5169.9%
Inhibrx Biosciences, Inc.June 07, 20241,787,70512.3%
Inhibrx, Inc.Sold outJune 03, 202400.0%
STANDARD BIOTOOLS INC.March 20, 202458,651,17015.3%
RayzeBio, Inc.Sold outFebruary 28, 202400.0%
Adaptive Biotechnologies CorpFebruary 14, 202429,993,70820.7%
Amylyx Pharmaceuticals, Inc.February 14, 20242,962,5554.4%
Edgewise Therapeutics, Inc.February 14, 20246,159,1469.7%
Five9, Inc.February 14, 20242,714,1173.7%
Ginkgo Bioworks Holdings, Inc.February 14, 2024143,085,1268.8%

View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-09-03
SC 13D/A2024-08-20
13F-HR2024-08-14
SC 13G2024-07-15
42024-06-18
42024-06-18
SC 13G/A2024-06-18
32024-06-07
SC 13G2024-06-07
42024-06-03

View VIKING GLOBAL INVESTORS LP's complete filings history.

Compare quarters

Export VIKING GLOBAL INVESTORS LP's holdings